122 related articles for article (PubMed ID: 36121076)
21. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
[TBL] [Abstract][Full Text] [Related]
22. Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs.
Li K; Zhu X; Li L; Ning R; Liang Z; Zeng F; Su F; Huang S; Yang X; Qu S
Sci Rep; 2020 Mar; 10(1):5161. PubMed ID: 32198434
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.
Du ZM; Hu LF; Wang HY; Yan LX; Zeng YX; Shao JY; Ernberg I
PLoS One; 2011 Apr; 6(4):e19137. PubMed ID: 21541331
[TBL] [Abstract][Full Text] [Related]
24. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2.
Yu D; Han GH; Zhao X; Liu X; Xue K; Wang D; Xu CB
Cell Oncol (Dordr); 2020 Apr; 43(2):249-261. PubMed ID: 31884576
[TBL] [Abstract][Full Text] [Related]
27. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
28. Direct quantification of circulating miRNAs in different stages of nasopharyngeal cancerous serum samples in single molecule level with total internal reflection fluorescence microscopy.
Ho SL; Chan HM; Ha AW; Wong RN; Li HW
Anal Chem; 2014 Oct; 86(19):9880-6. PubMed ID: 25207668
[TBL] [Abstract][Full Text] [Related]
29. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
Liu N; Tang LL; Sun Y; Cui RX; Wang HY; Huang BJ; He QM; Jiang W; Ma J
Cancer Lett; 2013 Feb; 329(2):181-8. PubMed ID: 23142282
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
Cheng JZ; Chen JJ; Wang ZG; Yu D
Cancer Biomark; 2018; 23(1):107-123. PubMed ID: 29991129
[TBL] [Abstract][Full Text] [Related]
31. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
Gao W; Wong TS; Lv KX; Zhang MJ; Tsang RK; Chan JY
Head Neck; 2019 Mar; 41(3):780-792. PubMed ID: 30548946
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma.
Luan J; Wang J; Su Q; Chen X; Jiang G; Xu X
Oncotarget; 2016 Mar; 7(9):10513-21. PubMed ID: 26824418
[TBL] [Abstract][Full Text] [Related]
33. Association Between
Lao TD; Le TAH
Genet Test Mol Biomarkers; 2019 Nov; 23(11):815-822. PubMed ID: 31693455
[No Abstract] [Full Text] [Related]
34. Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis.
Luo SD; Tsai HT; Hwang CF; Chiu TJ; Li SH; Hsu YL; Hsiao CC; Chen CH
J Exp Clin Cancer Res; 2022 Jul; 41(1):215. PubMed ID: 35778755
[TBL] [Abstract][Full Text] [Related]
35. miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.
Qiu F; Sun R; Deng N; Guo T; Cao Y; Yu Y; Wang X; Zou B; Zhang S; Jing T; Ling T; Xie J; Zhang Q
PLoS One; 2015; 10(3):e0120969. PubMed ID: 25786138
[TBL] [Abstract][Full Text] [Related]
36. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
[TBL] [Abstract][Full Text] [Related]
37. The mechanism of miR-410-3p and miR-34c in nasopharyngeal carcinoma development and progression.
Zhu L; Ni Z; Liang K; Tang Y; Zhao M; Chen C; Yuan X
Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):114-120. PubMed ID: 34817330
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma.
Wang J; Kong J; Nie Z; Chen D; Qiang J; Gao W; Chen X
Int J Med Sci; 2020; 17(11):1499-1507. PubMed ID: 32669952
[No Abstract] [Full Text] [Related]
39. Integrative analysis of miRNAs-mRNAs reveals that miR-182 up-regulation contributes to proliferation and invasion of nasopharyngeal carcinoma by targeting PTEN.
Shi Z; Wang R; Huang L; Chen X; Xu M; Zha D; Ma Y
Aging (Albany NY); 2020 Jun; 12(12):11568-11578. PubMed ID: 32541092
[TBL] [Abstract][Full Text] [Related]
40. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
